| Arthur Nelson West, MD | |
|
1160 Varnum St Ne, 311, Washington, DC 20017-2107 | |
| (202) 832-2880 | |
| (202) 832-0456 |
| Full Name | Arthur Nelson West |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 41 Years |
| Location | 1160 Varnum St Ne, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407818800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD14799 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Noting USAID on Wednesday released USAID Forward, "a progress report on its three-year-old reform effort ... which in the words of Administrator Rajiv Shah has the ultimate goal of putting 'ourselves out of business,'" Bill Lane, the director of International Governmental Affairs for Caterpillar, and Carolyn Miles, president and CEO of Save the Children - co-presidents of the U.S. Global Leadership Coalition - write in The Hill's "Congress Blog," "We applaud the goals of USAID Forward to modernize and strengthen U.S. development programs, and while every indicator in the report is not perfect, the reforms are moving in the right direction."
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today announced that it has received approval to advance to the next phase of its New Zealand Phase II human clinical trial with its groundbreaking DIABECELL®. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its DIABACELL® implants.
Dr Sherif said: "Earlier studies on the impact of gender on outcome after transcatheter aortic valve implantation (TAVI) have had conflicting results. A Canadian study reported in 641 consecutive patients that female sex is associated with a better long-term and short-term survival after TAVI.1 An Italian study of 305 high risk patients found no gender differences in composite safety and efficacy endpoints at 30 days and one year after TAVI."2
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
› Verified 7 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
Noting USAID on Wednesday released USAID Forward, "a progress report on its three-year-old reform effort ... which in the words of Administrator Rajiv Shah has the ultimate goal of putting 'ourselves out of business,'" Bill Lane, the director of International Governmental Affairs for Caterpillar, and Carolyn Miles, president and CEO of Save the Children - co-presidents of the U.S. Global Leadership Coalition - write in The Hill's "Congress Blog," "We applaud the goals of USAID Forward to modernize and strengthen U.S. development programs, and while every indicator in the report is not perfect, the reforms are moving in the right direction."
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today announced that it has received approval to advance to the next phase of its New Zealand Phase II human clinical trial with its groundbreaking DIABECELL®. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its DIABACELL® implants.
Dr Sherif said: "Earlier studies on the impact of gender on outcome after transcatheter aortic valve implantation (TAVI) have had conflicting results. A Canadian study reported in 641 consecutive patients that female sex is associated with a better long-term and short-term survival after TAVI.1 An Italian study of 305 high risk patients found no gender differences in composite safety and efficacy endpoints at 30 days and one year after TAVI."2
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arthur Nelson West, MD 1160 Varnum St Ne, 311, Washington, DC 20017-2107 Ph: (202) 832-2880 | Arthur Nelson West, MD 1160 Varnum St Ne, 311, Washington, DC 20017-2107 Ph: (202) 832-2880 |
News Archive
Noting USAID on Wednesday released USAID Forward, "a progress report on its three-year-old reform effort ... which in the words of Administrator Rajiv Shah has the ultimate goal of putting 'ourselves out of business,'" Bill Lane, the director of International Governmental Affairs for Caterpillar, and Carolyn Miles, president and CEO of Save the Children - co-presidents of the U.S. Global Leadership Coalition - write in The Hill's "Congress Blog," "We applaud the goals of USAID Forward to modernize and strengthen U.S. development programs, and while every indicator in the report is not perfect, the reforms are moving in the right direction."
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today announced that it has received approval to advance to the next phase of its New Zealand Phase II human clinical trial with its groundbreaking DIABECELL®. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its DIABACELL® implants.
Dr Sherif said: "Earlier studies on the impact of gender on outcome after transcatheter aortic valve implantation (TAVI) have had conflicting results. A Canadian study reported in 641 consecutive patients that female sex is associated with a better long-term and short-term survival after TAVI.1 An Italian study of 305 high risk patients found no gender differences in composite safety and efficacy endpoints at 30 days and one year after TAVI."2
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
› Verified 7 days ago
Dr. Adefolaju Oketokun, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |